Subscribe for notification
Google Translate
РусскийРусский EnglishEnglish

Reig Jofre S.A.

Reig Jofre S.A.

Reig Jofre History:

1929 Foundation in Barcelona (Spain) by the pharmacist Ramon Reig Jofre. The current CEO is the third generation of the Reig family.

1964-1999 Creation of a portfolio of prescription and OTC products in dermatology and respiratory through the combination of own developments and various acquisitions in Spain

1978-2009 Specialization in sterile injectables

1978 First freeze dryer

1998 Acquisition of Sant Joan Despí plant

2009 New vial plant

2000-2004 Antibiotic specialization

2000 acquisition of the Toledo plant

2003 Construction of the Cephalosporin plant

2004 Acquisition of antibiotic licenses Anaclosil, Pulmictan, Ardine, and ArdineClav

2015 Reig Jofre merges with the company Natraceutical, a benchmark in Europe in the sector of nutritional supplements for sale in pharmacies through its Forté Pharma brand and becomes the 5th Spanish pharmaceutical company by turnover, listed on the Spanish stock market

2019 Acquisition of the Joint Health and Pain product portfolio from Bioiberica company.

Collaboration agreements in the development of new products.

Market entry in South Korea with the injectable for hospital use Remifentanil.

Reig Jofre products are available in 130 countries.

Sort By:
Properties and indications: Deripil Topical Gel 2% contains erythromycin for topical dermatological use; it is used for infections of the skin and soft tissues (pustular skin diseases, including youthful acne, infected wounds, pressure sores, burns of the II-III stage, trophic ulcer..
Properties and indications: Deripil tonic with 2% erythromycin for local use in case of skin infections, pustular diseases, acne, infected wounds, etc.; erythromycin is a macrolide antibiotic that has an antibacterial effect and is active against many gram-positive bacteria; l..